Evidence map›Paper›PMID 38410127›Full record

ArticleFrontiers in public health2023

Frequency of SARS-CoV-2 variants identified by real-time PCR in the AUNA healthcare network, Peru.

Tamin Ortiz-Gómez, Andrea C Gomez, Brigitte Chuima, Alejandra Zevallos, Karen Ocampo, Diana Torres, Joseph A Pinto

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Tamin Ortiz-GómezLaboratorios AUNA, Área de Biología Molecular, Lima, Peru.
Andrea C GomezCentro de Investigación Básica y Translacional, AUNA IDEAS, Lima, Peru.
Brigitte ChuimaLaboratorios AUNA, Área de Biología Molecular, Lima, Peru.
Alejandra ZevallosEscuela Profesional de Medicina Humana, Universidad Privada San Juan Bautista, Lima, Peru.
Karen OcampoLaboratorios AUNA, Área de Biología Molecular, Lima, Peru.
Diana TorresLaboratorios AUNA, Área de Biología Molecular, Lima, Peru.
Joseph A PintoCentro de Investigación Básica y Translacional, AUNA IDEAS, Lima, Peru.
Group for the Analysis of Development · PEUniversidad Norbert Wiener · PEUniversidad Privada San Juan Bautista · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: In Peru, on 11 February 2023, the Ministry of Health registered 4 million patients infected with COVID-19 and around 219,260 deaths. In 2020, the SARS-CoV-2 virus was acquiring mutations that impacted the properties of transmissibility, infectivity, and immune evasion, leading to new lineages. In the present study, the frequency of COVID-19 variants was determined during 2021 and 2022 in patients treated in the AUNA healthcare network. Methods: The methodology used to detect mutations and identify variants was the Allplex™ SARS-CoV-2 Variants Assay I, II, and VII kit RT-PCR. The frequency of variants was presented by epidemiological weeks. Results: In total, 544 positive samples were evaluated, where the Delta, Omicron, and Gamma variants were identified. The Delta variant was found in 242 (44.5%) patients between epidemiological weeks 39 and 52 in 2021. In the case of Gamma, it was observed in 8 (1.5%) patients at weeks 39, 41, 43, 45, and 46 of 2021. The Omicron variant was the most frequent with 289 (53.1%) patients during weeks 49 to 52 of 2021 and 1 to 22 of 2022. During weeks 1 through 22 of 2022, it was possible to discriminate between BA. 1 ( Conclusion: The rapid identification of COVID-19 variants through the RT-PCR methodology contributes to timely epidemiological surveillance, as well as appropriate patient management.

Indexed as

COVID-19SARS-CoV-2COVID-19 TestingHumansPeruReal-Time Polymerase Chain ReactionCOVID-19epidemiological monitoringRT-PCR methodSARS-CoV-2 variantssurveillance & forecast system

Identifiers

PMID38410127
PMCPMC10894931
OpenAlexW4391750140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.